Skip to main content

Table 1 Characteristics of persons who received one or more doses of HPV vaccine, 2008 - 2014

From: HPV Vaccine utilization, Alberta 2008/09 – 2013/14 School year

   Public funding Private funding Mixed funding Total persons vaccinated N (%)a
Total [N, (%a)]   141,877 (83.8) 26,823 (15.8) 559 (0.3) 169,259
School year 2008/09 13,420 4,101 79 17,600 (10.4)
  2009/10 25,693 4,554 708 30,355 (17.9)
  2010/11 28,231 3,796 90 32,117 (19.0)
  2011/12 28,971 3,787 79 32,837 (19.4)
  2012/13 21,326 4,487 93 25,906 (15.3)
  2013/14 24,236 6,098 110 30,444 (18.0)
Age in years 9 397 10 11 408 (0.2)
  10b 50,787 43 16 50,846 (30.0)
  11b 30,670 67 10 30,747 (18.2)
  12 2,734 121 15 2,870 (1.7)
  13 1,730 200 18 1,948 (1.2)
  14c 30,615 364 108 31,087 (18.4)
  15c 19,504 954 91 20,549 (12.1)
  16 1,686 1,608 52 3,346 (2.0)
  17 1,200 2,151 54 3,405 (2.0)
  18 740 2,259 43 3,042 (1.8)
  19 294 1,953 31 2,278 (1.3)
  20 229 1,905 25 2,159 (1.3)
  21 to 26 1,150 9,301 76 10,527 (6.2)
  27 to 45 135 5,474 19 5,628 (3.3)
  >45 4 413 0 417 (0.3)
Gender Female 141,661 24,180 545 166,386 (98.3)
  Male 216 2,643 14 2,873 (1.7)
Doses received One dose 4,206 7,715 0 11,921 (7.0)
  Two doses 9,599 6,316 47 15,962 (9.4)
  Three doses 128,072 12,792 512 141,376 (83.5)
Rural/Urban Residence Rural 29,446 3,804 163 33,413 (19.8)
  Urban 112,431 23,019 396 135,846 (80.3)
Income quintile Q1 27,716 3,556 100 31,372 (18.5)
  Q2 28,184 4,664 106 32,954 (19.5)
  Q3 25,515 5,089 91 30,695 (18.1)
  Q4 30,991 6,591 140 37,722 (22.3)
  Q5 29,471 6,923 122 36,516 (21.6)
Type of HPV vaccine qHPV 141,851 25,141 536 167,528 (99.0)
  bHPV 11 1,682 23 1,716 (1.0)
  U/Kd 15 0 0 15 (0)
  1. aSome percentages may not add to 100 due to rounding
  2. bMost children aged 10 or 11 years are grade 5 students
  3. cMost children aged 14 or 15 years are grade 9 students
  4. dU/K = unknown